News & Alerts
-
Jan- 2024 -4 January
Hi-Tech Pharmaceuticals Expands Production Capabilities to Revolutionize Dietary Supplements and OTC Drugs
Hi-Tech Pharmaceuticals, Inc., a leading global healthcare supplier, has announced a significant expansion in its manufacturing capabilities for dietary supplements…
Read More » -
4 January
Novartis Secures Groundbreaking $100 Million Deal with Voyager for Cutting-Edge Gene Therapy Partnership
On January 2, Voyager Therapeutics announced a significant licensing deal with Swiss-based drugmaker Novartis, wherein Novartis would make an upfront…
Read More » -
4 January
Glenmark Makes History: Unveils India’s First Biosimilar of Liraglutide, a Game-Changer in Diabetes Treatment
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular10,11 anti-diabetic drug, Liraglutide, for the…
Read More » -
4 January
MediLink’s Global Pact with Roche Unveils Revolutionary Oncology Breakthrough
MediLink Therapeutics has recently unveiled a groundbreaking collaboration and license agreement with Roche, a leading pharmaceutical company, for the development…
Read More » -
3 January
US FDA Approvals Bounce Back In 2023, Sparking Hopes of a Biotech Recovery
The surge in U.S. Food and Drug Administration (FDA) approvals in 2023 has ignited optimism within the biotech industry, signaling…
Read More » -
2 January
Ascentage Pharma Takes Center Stage: CEO Dr. Dajun Yang to Unveil Innovations at 42nd J.P. Morgan Healthcare Conference
Ascentage Pharma, a global biopharmaceutical company specializing in novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, has…
Read More » -
2 January
Dollar Landscape of Biological Drug API Manufacturing Services – A Decade of Growth and Collaboration (2023-2033)
The Biological Drug API Manufacturing Services Market Report for 2023-2033, presented by Research and Markets, underscores key developments in the…
Read More » -
2 January
AstraZeneca and Sanofi’s Breakthrough RSV Infant Shots Approved in China
In a significant development for infant healthcare, AstraZeneca and Sanofi have announced the approval of their respiratory syncytial virus (RSV)…
Read More » -
Dec- 2023 -30 December
FDA Issues Warning and Labeling Updates for Promethazine Hydrochloride Injection Products
In an announcement targeted at Health Care Professionals, the U.S. Food and Drug Administration (FDA) has released information regarding labeling…
Read More » -
30 December
Narcolepsy Drugs Market Soars to $5.95 Billion by 2030: Sodium Oxybate Takes Center Stage in Global Forecast
The Narcolepsy Drugs Market is on an upward trajectory, projected to reach a substantial value of US$5.95 billion by 2030,…
Read More »